Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition
Prestige Consumer Healthcare (NYSE:PBH) said it completed on June 15 the $1.045 billion acquisition of the Breathe Right brand and other brands from Foundation Consumer Healthcare. PBH expects the deal to expand its OTC portfolio; Breathe Right is projected to generate about $200M revenue and $95M core profit in 2025.
How this was made
The 30-second read
Why it matters
Acquiring Breathe Right (drug-free nasal strips) increases PBH’s brand concentration and category exposure; the article frames it as the largest brand by revenue and core profit contribution.
Market read
Deal size ($1.045B) and stated brand economics ($200M revenue, $95M core profit in 2025) are the main tradable inputs for PBH positioning.
What to watch
No discussion of competitive intensity in nasal strips, potential cannibalization vs existing PBH brands, or whether the $200M/$95M 2025 figures are sustainable post-acquisition.
Background
PBH is described as a leading independent OTC healthcare brand provider in North America, with brands including Monistat, Dramamine, and TheraTears.
Ticker impact
Prestige Consumer Healthcare completed the Breath Right brand acquisition from Foundation Consumer Healthcare for $1.045B on June 15.
Near-term: modest positive bias as investors price in portfolio expansion; medium-term: watch for integration and whether the $200M revenue/$95M core profit assumptions hold.
The article provides concrete deal size and stated expected brand scale, but lacks deal terms, financing details, and any guidance/earnings impact beyond long-term expectations.
Market effects
OTC consumer healthcare consolidation signal; could support sentiment for brand-acquisition strategies in nasal/respiratory categories.
Primarily US-distributed brands, with stated international growth optionality.
Limited—international expansion is mentioned but no specific geographies, timelines, or regulatory factors are provided.
Counterpoint
The article is promotional/analyst-style and provides only high-level deal economics; without financing and integration costs, the net accretion is uncertain.
Key entities
- public_companyPrestige Consumer Healthcare Inc.
Buyer of the Breathe Right brand and other brands; deal completed June 15 for $1.045B.
- private_or_otherFoundation Consumer Healthcare
Seller of the Breathe Right brand and certain other brands to PBH.
